单位:[a]Department of Endocrinology & Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Shandong Provincial Hospital Affiliated to Shandong First MedicalUniversity, Jinan 250021, China[b]Shandong Key Laboratory of Endocrinology and Lipid Metabolism & Shandong Prevention and Control Engineering Laboratory of Endocrine and Metabolic Diseases, ShandongFirst Medical University, Jinan 250021, China[c]Department of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China[d]Department of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun 130021, China[e]Department of Endocrinology and Metabolism, Fujian Medical University Union Hospital, Fuzhou 350001, China[f]Endocrinology Department, The Southwest Hospital of AMU, Chongqing 400038, China[g]Department of Biostatistics, School of Public Health, Shandong University, Jinan 250012, China[h]Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Chengdu 610041, China四川大学华西医院[i]Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China[j]Department of Endocrinology, The First People’s Hospital of Yinchuan, Yinchuan 750001, China[k]Department of Endocrinology, Nanjing Integrated Traditional Chinese and Western Medicine Hospital (the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine),Nanjing 210046, China[l]Department of Endocrinology and Metabolism & Institute of Endocrinology, the First Hospital of China Medical University, Shenyang 110000, China[m]Department of Endocrinology, the Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China[n]Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China内科学系大内科内分泌内科华中科技大学同济医学院附属同济医院[o]Department of Endocrinology, Yantai Yuhuangding Hospital Affiliated to Qingdao University Medical College, Yantai 264000, China[p]Department of Endocrinology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China江苏省人民医院[q]Department of Endocrinology and Metabolic Diseases, the Affiliated Hospital of Qingdao University, Qingdao 266000, China[r]Division of Endocrinology, Department of Internal Medicine, Inner Mongolia Autonomous Region People’s Hospital, Hohhot 010017, China[s]Department of Endocrinology, the Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010030, China[t]Department of Endocrinology & Beijing Institute of Geriatrics, National Health Commission, Beijing Hospital, Beijing 100000, China[u]Division of Endocrinology, Department of Internal Medicine, Xijing Hospital of Air Force Military Medical University, Xi’an 710032, China[v]National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100032, China[w]Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China
The aim of this study was to explore the associations of moderate-to-vigorous-intensity physical activity (MVPA) time and sedentary (SED) time with a history of cardiovascular disease (CVD) and multifactorial (i.e., blood pressure (BP), body mass index (BMI), low-density lipoprotein cholesterol (LDL-C), and gly-cated hemoglobin A1c (HbA1c)) control status among type 2 diabetes mellitus (T2DM) patients in China. A cross-sectional analysis of 9152 people with type 2 diabetes from the Multifactorial Intervention on Type 2 Diabetes (MIDiab) study was performed. Patients were grouped according to their self-reported MVPA time (low, < 150 min center dot week-1; moderate, 150 to < 450 min center dot week-1; high, >= 450 min center dot week-1) and SED time (low, < 4 h center dot d-1; moderate, 4 to < 8 h center dot d-1; high, >= 8 h center dot d-1). Participants who self-reported a history of CVD were identified as having a CVD risk. Odds ratios (ORs) and 95% confidence intervals (CIs) of CVD risk and multifactorial control status associated with MVPA time and SED time were estimated using mixed-effect logistic regression models, adjusting for China's geographical region characteristics. The participants had a mean +/- standard deviation (SD) age of (60.87 +/- 8.44) years, 44.5% were women, and 25.1% had CVD. After adjustment for potential confounding factors, an inverse association between high MVPA time and CVD risk that was independent of SED time was found, whereas this association was not observed in the moderate-MVPA group. A higher MVPA time was more likely to have a positive effect on the control of BMI. Compared with the reference group (i.e., those with MVPA time >= 450 min center dot week-1 and SED time < 4 h center dot d-1), CVD risk was higher in the low-MVPA group: The OR associated with an SED time < 4 h center dot d-1 was 1.270 (95% CI, 1.040-1.553) and that associated with an SED time >= 8 h center dot d-1 was 1.499 (95% CI, 1.149-1.955). We found that a high MVPA time (i.e., >= 450 min center dot week-1) was associated with lower odds of CVD risk regardless of SED time among patients with T2DM.(c) 2022 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
基金:
National Key Research and Development Program of China [2017YFC1309800]; Outstanding University Driven by Talents" Program and Academic Promotion Program of Shandong First Medical University [2019LJ007]; Key Research and Development Program of Shandong Province [2017CXGC1214]
第一作者单位:[a]Department of Endocrinology & Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Shandong Provincial Hospital Affiliated to Shandong First MedicalUniversity, Jinan 250021, China[b]Shandong Key Laboratory of Endocrinology and Lipid Metabolism & Shandong Prevention and Control Engineering Laboratory of Endocrine and Metabolic Diseases, ShandongFirst Medical University, Jinan 250021, China
共同第一作者:
通讯作者:
通讯机构:[a]Department of Endocrinology & Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Shandong Provincial Hospital Affiliated to Shandong First MedicalUniversity, Jinan 250021, China[b]Shandong Key Laboratory of Endocrinology and Lipid Metabolism & Shandong Prevention and Control Engineering Laboratory of Endocrine and Metabolic Diseases, ShandongFirst Medical University, Jinan 250021, China[w]Department of Endocrinology, Shandong Provincial Hospital, Shandong University, Jinan 250021, China
推荐引用方式(GB/T 7714):
Yafei Wu,Guijun Qin,Guixia Wang,et al.Physical Activity, Sedentary Behavior, and the Risk of Cardiovascular Disease in Type 2 Diabetes Mellitus Patients: The MIDiab Study[J].ENGINEERING.2023,20:26-35.doi:10.1016/j.eng.2022.05.013.
APA:
Yafei Wu,Guijun Qin,Guixia Wang,Libin Liu,Bing Chen...&Jiajun Zhao.(2023).Physical Activity, Sedentary Behavior, and the Risk of Cardiovascular Disease in Type 2 Diabetes Mellitus Patients: The MIDiab Study.ENGINEERING,20,
MLA:
Yafei Wu,et al."Physical Activity, Sedentary Behavior, and the Risk of Cardiovascular Disease in Type 2 Diabetes Mellitus Patients: The MIDiab Study".ENGINEERING 20.(2023):26-35